Clinical trial
Safety and Blood Levels of Tenofovir Disoproxil Fumarate in HIV Infected…
NCT00120471 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00120471 |
|---|---|
| Title | Safety and Blood Levels of Tenofovir Disoproxil Fumarate in HIV Infected Pregnant Women and Their Babies |
| Official title | A Phase I Open Label Trial of the Safety and Pharmacokinetics of Tenofovir Disoproxil Fumarate in HIV-1 Infected Pregnant Women and Their Infants |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH National Institute on Drug Abuse (NIDA) National Institute of Mental Health (NIMH) |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Tenofovir disoproxil fumarate |
| Enrollment | 122 |
| Start date | Nov 1, 2006 |
| Primary completion | Oct 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | Jul 18, 2005 |
| Last update posted | Nov 1, 2021 |
| Countries | Brazil, Malawi |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: